Apollomics APLM
NASDAQ APLM
$21.59 -0.46 (-2.07%)
As of: Oct 21, 2026 · 11:28 AM EDT

Apollomics (APLM) Current Leases (2022 - 2025)

Updated

Apollomics (APLM) reported Current Leases of $209,000 for Q4 2025, down 10.3% from $233,000 a year earlier.

Analysis

Apollomics (APLM) Current Leases (2022 - 2025) Analysis & Trends

Dating back to Q4 2021, Apollomics' Current Leases record includes 8 quarters.

  • Current Leases has declined for four consecutive years, with a four-year compound annual growth rate of -57.4% (FY2021 to FY2025).
  • By year, Current Leases came in at $233,000 in FY2024 (-36.3%), $366,000 in FY2023 (-88.0%), $3.05 million in FY2022 (-51.8%) and $6.34 million in FY2021.
  • Five-year quarterly Current Leases spans a low of $203,000 in Q2 2025 and a high of $6.34 million in Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,133.90 Bn 1,102.48 Bn 19.71 Bn -
2 Johnson & Johnson 616.46 Bn 534.99 Bn 17.26 Bn -
3 AbbVie 501.26 Bn 474.37 Bn 12.70 Bn -
4 Merck 367.00 Bn 321.38 Bn 12.21 Bn -
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn -
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn -
7 Amgen 235.82 Bn 191.22 Bn 7.24 Bn -
8 Gilead Sciences 190.63 Bn 164.82 Bn 6.22 Bn -
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn -
10 Apollomics 31.22 Mn -9.87 Mn - 209,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 209,000.00
Jun 30, 2025 203,000.00
Dec 31, 2024 233,000.00
Jun 30, 2024 264,000.00
Dec 31, 2023 158,000.00
Dec 31, 2022 614,000.00
API Access

Apollomics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=APLM&period=max&api_key=YOUR_API_KEY